HCPLive | The preeminent online destination for tools, techniques, and information for healthcare professionals

You may type link codes into the search box above.

| Feedback | Submit an Article

articles > P-6

Features

Enzyme’s Affects Reveal Potential New Treatment for Heart Arrhythmias and Failure

The enzyme calmodium kinase II reduces the heart's negative functions while maintaining positive ones, making the enzyme a potential new treatment for heart arrhythmias and failure.

A Shutter Island of Your Own
Ten Questions to Ask Yourself before Choosing a New Bank
Time to Rebalance?
E-prescribing Reduces Medication Errors
Treating Chronic Pain in Pediatric Patients
The Link Between Diabetes and Eating Disorders
FDA Oncology Updates
Cushing's Syndrome Pharma Focus: Cortisol-Inhibiting Medications
Online CME: Improving Outcomes in Acromegaly and Cushing’s Disease - Identifying Appropriate Patients for Medical Management
eAbstract: Sarcoidosis Following Cushing's Syndrome: A Report of Two Cases and Review of the Literature
eAbstract: Pseudotumor Cerebri after Surgical Remission of Cushing's Disease
eAbstract: Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s Syndrome
Clinical Trial: New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Clinical Trial: Long-term Cardiovascular Risk in Cured Cushing's Patients
Clinical Trial: A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Pituitary Center Videos – Cushing’s Syndrome
The Educated Patient: Mayoclinic.com - Cushing's Syndrome
Patient Education: Cushing's Syndrome

HCPLive \| The American Journal of Managed Care \| Pharmacy Times \| OTCGuide.net \| Politics \| ONCLive Intellisphere, LLC l 666 Plainsboro Road, Building 300, Plainsboro, NJ 08536 l P 609-716-7777 l F 609-716-4747 About Us \| Contact Us \| Privacy Policy l Terms of Service
	Copyright ©MDNG 2006-2010 Intellisphere, LLC All Rights Reserved